HIV-1 Drug Resistance and Dependence
Author Information
Author(s): Chris Baldwin, Ben Berkhout
Primary Institution: Academic Medical Center of the University of Amsterdam
Hypothesis
The evolution of drug-dependence in HIV-1 variants occurs through the selection of drug-resistance mutations followed by compensatory mutations that enhance viral fitness in the presence of the drug.
Conclusion
Drug-dependent HIV-1 variants can emerge during therapy, which may complicate treatment and require modifications to drug regimens.
Supporting Evidence
- Drug-dependent HIV-1 variants can emerge during antiviral therapy.
- The evolution of drug-dependence often involves initial drug-resistance mutations followed by compensatory mutations.
- Drug-dependent variants may not replicate without the drug, complicating treatment strategies.
Takeaway
Some HIV viruses can become dependent on a drug to survive, meaning they can't replicate without it, which can make treating the infection tricky.
Methodology
The review discusses various studies on HIV-1 variants selected for drug-dependence and resistance mutations.
Limitations
The review may not cover all possible drug-dependent variants and their clinical implications.
Participant Demographics
The review references studies involving patients undergoing T20 therapy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website